ArticleJAMA oncology2022

Novel Quadruplets and the Age of Immunotherapies in the Treatment of Newly Diagnosed Multiple Myeloma.

Dickran Kazandjian et al.PubMed ↗Publisher ↗

No numbers read from the abstract.